Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Kallikrein 7 Antikörper (C-Term)

KLK7 Reaktivität: Human WB, IHC (p), FACS Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN545339
  • Target Alle Kallikrein 7 (KLK7) Antikörper anzeigen
    Kallikrein 7 (KLK7)
    Bindungsspezifität
    • 15
    • 12
    • 6
    • 6
    • 5
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    C-Term
    Reaktivität
    • 44
    • 30
    • 18
    • 2
    • 2
    • 2
    • 2
    • 1
    Human
    Wirt
    • 72
    • 6
    Kaninchen
    Klonalität
    • 75
    • 3
    Polyklonal
    Konjugat
    • 29
    • 13
    • 11
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser Kallikrein 7 Antikörper ist unkonjugiert
    Applikation
    • 49
    • 30
    • 25
    • 13
    • 13
    • 8
    • 7
    • 6
    • 4
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Flow Cytometry (FACS)
    Verwendungszweck
    Rabbit polyclonal antibody raised against synthetic peptide of KLK7.
    Kreuzreaktivität
    Human
    Immunogen
    A synthetic peptide (conjugated with KLH) corresponding to C-terminus of human KLK7.
    Top Product
    Discover our top product KLK7 Primärantikörper
  • Applikationshinweise
    Western Blot (1:1000)
    Immunohistochemisty (1:10-1:50)
    Flow Cytometry (1:10-1:50)
    The optimal working dilution should be determined by the end user.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    In PBS (0.09 % sodium azide)
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store at 4°C. For long term storage store at -20°C.
    Aliquot to avoid repeated freezing and thawing.
  • Ishida-Yamamoto, Deraison, Bonnart, Bitoun, Robinson, OBrien, Wakamatsu, Ohtsubo, Takahashi, Hashimoto, Dopping-Hepenstal, McGrath, Iizuka, Richard, Hovnanian: "LEKTI is localized in lamellar granules, separated from KLK5 and KLK7, and is secreted in the extracellular spaces of the superficial stratum granulosum." in: The Journal of investigative dermatology, Vol. 124, Issue 2, pp. 360-6, (2005) (PubMed).

    Planque, de Monte, Guyetant, Rollin, Desmazes, Panel, Lemarié, Courty: "KLK5 and KLK7, two members of the human tissue kallikrein family, are differentially expressed in lung cancer." in: Biochemical and biophysical research communications, Vol. 329, Issue 4, pp. 1260-6, (2005) (PubMed).

    Vasilopoulos, Cork, Murphy, Williams, Robinson, Duff, Ward, Tazi-Ahnini: "Genetic association between an AACC insertion in the 3'UTR of the stratum corneum chymotryptic enzyme gene and atopic dermatitis." in: The Journal of investigative dermatology, Vol. 123, Issue 1, pp. 62-6, (2004) (PubMed).

  • Target
    Kallikrein 7 (KLK7)
    Andere Bezeichnung
    KLK7 / Kallikrein-7 (KLK7 Produkte)
    Synonyme
    Prss6 antikoerper, SCCE antikoerper, PRSS6 antikoerper, hK7 antikoerper, kallikrein related-peptidase 7 (chymotryptic, stratum corneum) antikoerper, kallikrein-related peptidase 7 antikoerper, kallikrein related peptidase 7 antikoerper, Klk7 antikoerper, KLK7 antikoerper
    Gen-ID
    5650
    Pathways
    Komplementsystem
Sie sind hier:
Kundenservice